(Q39036703)

8 September 2017

title

Mouse glioma immunotherapy mediated by A2B5+ GL261 cell lysate-pulsed dendritic cells (English)

1 reference

8 September 2017

1 reference

1 reference

7

Liangfu Zhou

1 reference

8 September 2017

6

Ying Mao

1 reference

8 September 2017

Ming Xu

1

1 reference

8 September 2017

Yu Yao

2

1 reference

8 September 2017

Wei Hua

3

1 reference

8 September 2017

Zhebao Wu

4

1 reference

8 September 2017

Ping Zhong

5

1 reference

8 September 2017

Feifei Luo

8

1 reference

8 September 2017

Yiwei Chu

9

1 reference

8 September 2017

publication date

8 January 2014

1 reference

Journal of Neuro-Oncology

8 September 2017

published in

1 reference

8 September 2017

volume

116

1 reference

8 September 2017

issue

3

1 reference

8 September 2017

page(s)

497-504

1 reference

Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1334-9

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1334-9

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1334-9

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1334-9

Immune therapeutic targeting of glioma cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1334-9

Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1334-9

A2B5 cells from human glioblastoma have cancer stem cell properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1334-9

SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1334-9

Persistence of CD133+ cells in human and mouse glioma cell lines: detailed characterization of GL261 glioma cells with cancer stem cell-like properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1334-9

CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1334-9

New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1334-9

Site-specific anti-tumor immunity: differences in DC function, TGF-beta production and numbers of intratumoral Foxp3+ Treg

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1334-9

In vivo bioluminescence imaging in an experimental mouse model for dendritic cell based immunotherapy against malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1334-9

Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1334-9

Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1334-9

Investigation of immunosuppressive mechanisms in a mouse glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1334-9

Glioma-associated cancer-initiating cells induce immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1334-9

Immunobiological characterization of cancer stem cells isolated from glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1334-9

Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1334-9

The CD133+ tumor stem-like cell-associated antigen may elicit highly intense immune responses against human malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1334-9

Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1334-9

Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1334-9

Systemic inhibition of transforming growth factor-beta in glioma-bearing mice improves the therapeutic efficacy of glioma-associated antigen peptide vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1334-9

Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model

21 January 2018

1 reference

PubMed

12 December 2020

Glioma stem cells: better flat than round

1 reference

PubMed

12 December 2020

Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas

1 reference

PubMed

12 December 2020

1 reference

12 December 2020

10.1007/S11060-013-1334-9

Identifiers

DOI

1 reference

8 September 2017

1 reference